L-rhamnose and L-fucose suppress cancer growth in mice

Central European Journal of Biology

Volumn 6, Issue 1, 2011, Pages 1-9

  Tomsik, Pavel ^a   Soukup, Tomas ^a   Cermakova, Eva ^a   Micuda, Stanislav ^a   Niang, Mohamed ^a   Sucha, Lenka ^a   Rezacova, Martina ^a  

^a CHARLES UNIVERSITY   (Czech Republic)

Author keywords

Ehrlich Tumour; In vivo; L Fucose; L Rhamnose; Mitotic Index; Survival Rate; Tumour Growth

Indexed keywords

MUS;

EID: 78650414732     PISSN: 1895104X     EISSN: 16443632     Source Type: Journal    
DOI: 10.2478/s11535-010-0087-0     Document Type: Article

References (48)

1. Wang J. W., Ambros R. A., Weber P. B., Rosano T. G., Fucosyltransferase and α-L-fucosidase activities and fucose levels in normal and malignant endometrial tissue, Cancer Res., 1995, 55, 3654-3658.
2. Hakomori S., Aberrant glycosylation in tumors and tumor-associated carbohydrate antigens, Adv. Cancer Res., 1989, 52, 257-331.
3. Fernandez-Rodriguez J., Paez de la Cadena M., Martinez-Zorzano V. S., Rodriguez-Berrocal F. J., Fucose levels in sera and in tumours of colorectal adenocarcinoma patients, Cancer Lett., 1997, 121, 147-153.
4. Patel P. S., Adhvaryu S. G., Balar D. B., Parikh B. J., Shah P. M., Clinical application of serum levels of sialic acid, fucose and seromucoid fraction as tumour markers in human leukemias, Anticancer Res., 1994, 14, 747-751.
5. Hakomori S., Tumor-associated carbohydrate antigens defining tumor malignancy: basis for development of anti-cancer vaccines, Adv. Exp. Med. Biol., 2001, 491, 369-402.
6. Zhao Y. Y., Takahashi M., Gu J.-G., Miyoshi E., Matsumoto A., Kitazume S., et al., Functional roles of N-glycans in cell signaling and cell adhesion in cancer, Cancer Sci., 2008, 99, 1304-1310.
7. Listinsky J. J., Listinsky C. M., Alapati V., Siegal G. P., Cell surface fucose ablation as a therapeutic strategy for malignant neoplasms, Adv. Anat. Pathol., 2001, 8, 330-337.
8. Sakuma K., Fujimoto I., Hitoshi S., Tanaka F., Ikeda T., Tanabe K., et al., An N-glycan structure correlates with pulmonary metastatic ability of cancer cells, Biochem. Biophys. Res. Commun., 2006, 340, 829-835.
9. Takahashi T., Ikeda Y., Miyoshi E., Yaginuma Y., Ishikawa M., Taniguchi N., α1, 6fucosyltransferase is highly and specifically expressed in human ovarian serous adenocarcinomas, Int. J. Cancer, 2000, 88, 914-919.
10. Geng F., Shi B. Z., Yuan Y. F., Wu X. Z., The expression of core fucosylated E-cadherin in cancer cells and lung cancer patients: prognostic implications, Cell Res., 2004, 14, 423-433.
11. Miyoshi E., Noda K., Ko J. H., Ekuni A., Kitada T., Uozumi N., et al., Overexpression of α1-6 fucosyltransferase in hepatoma cells suppresses intrahepatic metastasis after splenic injection in athymic mice, Cancer Res., 1999, 59, 2237-2243.
12. Osumi D., Takahashi M., Miyoshi E., Yokoe S., Lee S. H., Noda K., et al., Core fucosylation of E-cadherin enhances cell-cell adhesion in human colon carcinoma WiDr cells, Cancer Sci., 2009, 100, 888-895.
13. MacDougall S. L., Schwarting G. A., Parkinson D., Sullivan A. K., Increased fucosylation of glycolipids in a human leukaemia cell line (K562-Clone I) with decreased sensitivity to NK-mediated lysis, Immunology, 1987, 62, 75-80.
14. Becker D. J., Lowe J. B., Fucose: biosynthesis and biological function in mammals, Glycobiology, 2003, 13, 41R-53R.
15. Moriwaki K., Noda K., Furukawa Y., Ohshima K., Uchiyama A., Nakagawa T., et al., Deficiency of GMDS leads to escape from NK cell-mediated tumor surveillance through modulation of TRAIL signaling, Gastroenterology, 2009, 137, 188-198.
16. Falschlehner C., Emmerich C. H., Gerlach B., Walczak H., TRAIL signalling: Decisions between life and death, Int. J. Biochem. Cell Biol., 2007, 39, 1462-1475.
17. Ripka J., Adamany A., Stanley P., Two chinese hamster ovary glycosylation mutants affected in the conversion of GDP-mannose to GDP-fucose, Arch. Biochem. Biophys., 1986, 249, 533-545.
18. Mullen J. L., Rosato F. E., Allen T. R., Miller E. E., Roseman J., Rosato E. F., Continuous intravenous fucose therapy in rat mammary cancer II, J. Surg. Oncol., 1973, 5, 6-9.
19. Rosato F. E., Mullen J. L., Rosato E. F., Steiger E., Miller E. E., Continuous intravenous fucose treatment of rat mammary tumor, J. Surg. Oncol., 1972, 4, 94-101.
20. Wolfe D., Roseman J. M., Miller E., Seltzer M. H., Rosato F. E., The effect of L-fucose on rat mammary tumor growth I. In vivo Studies, J. Surg. Oncol., 1971, 3, 73-77.
21. Seltzer M. H., Roseman J. M., Wolfe D. E., Tsou K. C., Miller E. E., Rosato F. E., The effects of L-fucose on rat mammary tumor growth, Growth, 1969, 33, 353-359.
22. Roszkowski W., Beuth J., Ko H. L., Uhlenbruck G, Pulverer G., Blocking of lectin-like adhesion molecules on pulmonary cells inhibits lung sarcoma L-1 colonization in BALB/c-mice, Experientia, 1989, 45, 584-588.
23. Giraud M. F., Naismith J. H., The rhamnose pathway, Curr. Opin. Struct. Biol., 2000, 10, 687-696.
24. Ishihara H., Massaro D. J., Heath E. C., The metabolism of L-fucose. 3. The enzymatic synthesis of beta-L-fucose 1-phosphate, J. Biol. Chem., 1968, 243, 1103-1109.
25. Tymiak A. A., Norman J. A., Bolgar M., DiDonato G. C., Lee M. H., Parker W. L., et al., Physicochemical characterization of a ouabain isomer isolated from bovine hypothalamus, Proc. Natl. Acad. Sci. USA, 1993, 90, 8189-8193.
26. Malawista I., Davidson E. A., Isolation and identification of rhamnose from rabbit skin, Nature, 1961, 192, 871-872.
27. Condaminet B., Redziniak G., Monsigny M., Kieda C., Ultraviolet rays induced expression of lectins on the surface of a squamous carcinoma keratinocyte cell line, Exp. Cell. Res., 1997, 232, 216-224.
28. Tonetti M., Sturla L., Bisso A., Zanardi D., Benatti U., De Flora A., The metabolism of 6-deoxyhexoses in bacterial and animal cells, Biochimie, 1998, 80, 923-931.
29. Shi S. R., Chaiwun B., Young L., Cote R. J., Taylor C. R., Antigen retrieval technique utilizing citrate buffer or urea solution for immunohistochemical demonstration of androgen receptor in formalinfixed paraffin sections, J. Histochem. Cytochem., 1993, 41, 1599-1604.
30. Carter W. H. Jr, Wampler G. L., Stablein D. M., Campbell E. D., Drug activity and therapeutic synergism in cancer treatment, Cancer Res., 1982, 42, 2963-2971.
31. Tomšik P., Stoklasová A., Mičuda S., Niang M., Šuba P., Knižek J., et al., Evaluation of the antineoplastic activity of L-rhamnose in vitro. A comparison with 2-deoxyglucose, Acta Medica (Hradec Kralove), 2008, 51, 113-119.
32. Bekesi J. G., Molnar Z., Winzler R. J., Inhibitory effect of d-glucosamine and other sugar analogs on the viability and transplantability of ascites tumor cells, Cancer Res., 1969, 29, 353-359.
33. Fare G., Sammons D. C., Seabourne F. A., Woodhouse D. L., Lethal action of sugars on ascites tumor cells in vitro, Nature, 1967, 213, 308-309.
34. Tsuda M., Yoshioka Y., Kataoka N., Tachibana M., Maeda Y., Uehara N., et al., Isolation and characterization of carcinostatic liver factors active in vitro, Gann, 1965, 56, 69-74.
35. Roseman J. M., Miller E. E., Seltzer M. H., Wolfe D., Rosato F. E., The effect of L-fucose on rat mammary tumor growth II. In vitro studies, J. Surg. Oncol., 1971, 3, 79-88.
36. Cox R. P., Gesner B. M., Studies on the effects of simple sugars on mammalian cells in culture and characterization of the inhibition of 3T3 fibroblasts by L-fucose, Cancer Res., 1968, 28, 1162-1172.
37. Staňková J., Fucose-activated killer cells. I. Enhanced TNF-α mRNA accumulation and protein production, J. Leukoc. Biol., 1992, 52, 188-196.
38. Wild M. K., Lühn K., Marquardt T., Vestweber D., Leukocyte adhesion deficiency II: therapy and genetic defect, Cells Tissues Organs, 2002, 172, 161-173.
39. Chan J. Y, Nwokoro N. A., Schachter H., L-Fucose metabolism in mammals. The conversion of L-fucose to two moles of L-lactate, of L-galactose to L-lactate and glycerate, and of D-arabinose to L-lactate and glycollate, J. Biol. Chem., 1979, 254, 7060-7068.
40. Bekesi J. G., Winzler R. J., The metabolism of plasma glycoproteins. Studies on the incorporation of L-fucose-1-14C into tissue and serum in the normal rat, J. Biol. Chem., 1967, 242, 3873-3879.
41. Coffey J. W., Miller O. N., Sellinger O. Z., The metabolism of L-fucose in the rat, J. Biol. Chem., 1964, 39, 4011-4017.
42. Hallemeesch M. M., Lamers W. H., Soeters P. B., Deutz N. E., Increased lactulose/rhamnose ratio during fluid load is caused by increased urinary lactulose excretion, Am. J. Physiol Gastrointest. Liver Physiol., 2000, 278, G83-G88.
43. Taylor R. M., Bjarnason I., Cheeseman P., Davenport M., Baker A. J., Mieli-Vergani G., et al., Intestinal permeability and absorptive capacity in children with portal hypertension, Scand. J. Gastroenterol., 2002, 37, 807-811.
44. D'Antiga L., Dhawan A., Davenport M., Mieli-Vergani G., Bjarnason I., Intestinal absorption and permeability in paediatric short-bowel syndrome: a pilot study, J. Pediatr. Gastroenterol. Nutr., 1999, 29, 588-593.
45. Krecic M. R., Steiner J. M., Kern M. R., Williams D. A., Kinetics and postmucosal effects on urinary recovery of 5 intravenously administered sugars in healthy cats, Can. J. Vet. Res., 2003, 67, 88-93.
46. Bjarnason I., Macpherson A., Hollander D., Intestinal permeability: an overview, Gastroenterology, 1995, 108, 1566-1581.
47. Tomsik P., Sispera L., Rezacova M., Niang M., Stoklasova A., Cerman J., et al., Increased melibiose/rhamnose ratio in bile of rats with acute cholestasis, J. Gastroenterol. Hepatol., 2008, 23, 1934-1940.
48. Malagon I., Onkenhout W., Klok M., van der Poel P. F., Bovill J. G., Hazekamp M. G., Rhamnose and rhamnitol in dual sugar permeability tests, J. Pediatr. Gastroenterol. Nutr., 2006, 43, 265-266.